| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65682d3e437c225d79b93953b4b26392 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6093 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 |
| filingDate |
2020-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4c92a23c3f1bf681ebca534b06f5e45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_598028d6338164bda78dc0ba93970a8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb133a2c6d010afe500a8992e6563bcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9a46d6ed3eec9bfca3ad548e79ca864 |
| publicationDate |
2022-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022052212-A1 |
| titleOfInvention |
Use of fluorinated polyethylenimine in preparation of vaccine or preparation for preventing or treating diseases caused by viruses or bacteria |
| abstract |
The use of fluorinated polyethylenimine in the preparation of a vaccine or a preparation for preventing or treating diseases caused by viruses or bacteria. The use of fluorinated polyethylenimine, which provides an intracellular delivery system that enhances the vaccine delivery efficiency and antigen-specific immune response, not only acts as an antigen carrier, but can also function as an immune adjuvant. |
| priorityDate |
2020-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |